Indications and uses
Relieves headaches caused by throbbing pain, weakness, and/or dizziness, congested feeling, often stress-related.
WHP Be gone Congested Headache
- Manufacturer
- Washington Homeopathic Products
- Effective date
- 2014-05-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:08:49
Label at a glance#
ProductWHP Be gone Congested Headache TM
Active ingredientCALCIUM FLUORIDE, FERROSOFERRIC PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM CHLORIDE
Label structure8 sections
Dosage and administration
Adults: 2 pills every 3 hours for 2 days. Then 2 pills morning and night for 2 weeks. Children: 1 pill. Repeat as necessary.
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS
CALC FLUOR
FERRUM PHOS
NAT PHOS
NAT MUR
USES
Relieves headaches caused by throbbing pain, weakness, and/or dizziness, congested feeling, often stress-related.
KEEP OUT OF REACH OF CHILDREN
As with all medications, keep out of reach of children.
INDICATIONS
Indications:
Calc fluor 6c –cracking noise*
Ferrum phos 6c –worse motion*
Nat phos 6c –throbbing headache*
Nat mur 6c –blinding headache*
■ Weakness* ■ Dizziness* ■ Stress-related*
*These statements have not been reviewed by the Food and Drug Administration.
STOP USE AND ASK DOCTOR
If symptoms persist or recur, discontinue use. If pregnant or nursing a baby, consult a licensed practitioner before using this product.
DIRECTIONS
Adults: 2 pills every 3 hours for 2 days. Then 2 pills morning and night for 2 weeks.
Children: 1 pill.
Repeat as necessary.
INACTIVE INGREDIENTS
Sucrose/Lactose
PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68428-747-29 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a08f-d83d-e063-dadaa90ab31f | DRUG FACTS |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68428-747-14 | WHP Be gone Congested HeadacheTM | 300 in 1 BOTTLE, PLASTIC | PELLET | 300 | 1 | |
| 68428-747-29 | WHP Be gone Congested HeadacheTM | 1 in 1 BOX | PELLET | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68428-747 | WHP BE GONE CONGESTED HEADACHE TM (CALCIUM FLUORIDE - FERROSOFERRIC PHOSPHATE - SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE - SODIUM CHLORIDE) PELLET [WASHINGTON HOMEOPATHIC PRODUCTS] | 1 | Legacy NDC, 2 package rows | 20170609_a9ed9d0e-03c1-4cda-aaa9-3a9b0fc68e48.zip |
Products#
Every source-derived product name is available through these pages.
- WHP Be gone Congested Headache TM
- CALCIUM FLUORIDE - FERROSOFERRIC PHOSPHATE - SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE - SODIUM CHLORIDE
- CALCIUM FLUORIDE
- FLUORIDE ION
- SUCROSE
- LACTOSE
- FERROSOFERRIC PHOSPHATE
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
- PHOSPHATE ION
- SODIUM CHLORIDE
- CHLORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68428-747 | 68428-747-14, 68428-747-29 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM FLUORIDE | O3B55K4YKI | ACTIB |
| SUCROSE | C151H8M554 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| FERROSOFERRIC PHOSPHATE | 91GQH8I5F7 | ACTIB |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 70WT22SF4B | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2193909a-ed77-4a94-911f-8d327395b775 | a9ed9d0e-03c1-4cda-aaa9-3a9b0fc68e48 | 2014-05-08 | Warnings | 2193909a-ed77-4a94-911f-8d327395b775 a9ed9d0e-03c1-4cda-aaa9-3a9b0fc68e48 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.